Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q1 2026
Cardio Diagnostics Holdings (CDIO) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Cardio Diagnostics Holdings (CDIO) reported revenue of $3K for the first quarter 2026 (Q1 2026), +185% from a year earlier and -25% from the quarter before.
Cardio Diagnostics Holdings, Q1 2026: revenue $3K (+185% year over year), net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | -25% | +185% |
| Operating profit | −$1.8M | — | — |
| Net earnings | −$1.8M | — | — |
| Operating cash flow | −$1.6M | — | — |
What changed
Revenue was $3K in Q1 2026, up 185% year over year and down 25% from the previous quarter.
Operating costs exceeded revenue by $1.8M, an operating margin of -66598.4%. Total costs grew 10% against revenue growth of 185%. The fastest-growing cost line was General & admin (+14%). The quarter ended with a net loss of $1.8M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$1.6M. Non-cash charges added back $6K of depreciation and amortization and $25K of share-based compensation. Working capital and other items added $196K. Capital expenditures of $2K exceeded it, leaving free cash flow of −$1.6M.
Questions
What was Cardio Diagnostics Holdings' revenue in the first quarter 2026?
Cardio Diagnostics Holdings (CDIO) reported revenue of $3K for the first quarter 2026 (Q1 2026), +185% from a year earlier and -25% from the quarter before.